TrialBritish journal of cancer2005

Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.

S Lorenzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.